Neurotransmittesr Flashcards
Describe how synapses work briefly
Depolarisation in the terminal opens VGCC and Ca enters the terminal
Vesicles fuse and release neurotransmitter
Neurotransmitter diffuses across the synaptic cleft and binds to receptors on the post-synaptic membrane
Post-synaptic response depends upon the nature of the neurotransmitter and the nature of the receptor (GPCR or LGIC)
What are the three types of neurotransmitters and name some neurotransmitters in each class
Amino acids - GABA, glycine, glutamate
Biogenic amines - ACh, NA, dopamine, 5-HT, histamine
Peptides - dynorphin, enkephalins, substance P, somatostatin, cholecystokinin, neuropeptide Y
Which is the main excitatory neurotransmitter in the CNS and what are the main inhibitory neurotransmitters in the CNS
Main excitatory neurotransmitter is glutamate
Main inhibitory neurotransmitter for the brain is GABA
Main inhibitory neurotransmitter for the brainstem and spinal cord is glycine
What are the types of glutamate receptors
Ionotropic - have intrinsic ion channel permeable to Na, K and Ca
- AMPA receptors - Na/K
- Karinate receptors - Na/K
- NMDA receptors - Na/K and Ca
Metabotropic (mGluR1-7) - GPCRs linked to either changes in IP3 and Ca mobilisation or lead to inhibtion of adenylate cyclase and decreased cAMP
Describe the NMDA receptors
NMDA receptors cause depolarisation and increase excitability of the post-synaptic neurone
NMDA receptors require glutamate to bind and the cell to be depolarised to allow ion flow through the channel, otherwise the channel won’t open - silent synapse if only NMDA receptors
What role do glutamate receptors have in learning and memory
Glutamate activates NMDA receptors and so can up-regulate AMPA receptors to make synpases in learning and memory pathways stronger
Strong, high frequency stimulation causes long term potentiation with Ca entery through NMDA receptors important for this
Why is it harmful if NMDA receptors are activated excessively
Excessive activation of NMDA receptors results in too much Ca entery through NMDA receptors and causes excitotoxicity
This results in too much glutamate and toxicity to neurones
How do GABAA and glycine receptors inhibit transmission
GABAA and glycine have integral Cl channels and when opened, cause hyperpolarisation and an inhibitory post-synaptic potential which decreases action potential firing
What drugs can bind to GABAA receptors and what do the cause
Barbiturates and benzodiazepines bind to GABAA and enhance the response to GABA
Barbiturates have anxiolytic and sedative actions but are not used because of risk of dependency, tolerance and risk of fatal overdose. Sometimes used as anti-epileptic
Benzodiazepines have sedative and anxiolytic effects. They are used to treat anxiety, insomnia and epilepsy
Where does ACh act as a neurotransmitter and what is its mechanism of action in the CNS
ACh acts at neuromuscular junctions, ganglion synpases in the ANS, post-synaptic ganglionic parasympathetics and as a central neurotransmitter at nicotinic and muscarinic receptors in the brain
Acts by enhancing release of other neurotransmitters
Describe the origin of cholinergic neurones, where they project to and what the cholingeric pathways are involved in
Cholinergic neurones originate in the basal forebrain and brainstem and give diffuse projections to many parts of the cortex and hippocampus
Also have local cholinergic interneurones, e.g. in corpus striatum
Cholingeric pathways are involved in arousal, learning, memory and motor control
What is degradation of cholingeric neurones associated with
Degradation of cholingeric neurones in the nucleus basalis is associated with Alzheimer’s disease
Give cholinesterase inhibitors given to alleviate symptoms as they enhance the amount of ACh in the synpatic cleft
What pathways are found in the dopaminergic pathways and what are the pathways involved in
Nigrostriatal pathway - motor control
Mesocortical and mesolimbic pathways - mood, arousal and reward
What is the assocaition between Parkinson’s disease and dopaminergic pathways and what is used to treat Parkinson’s
Parkinson’s is associated with a loss of dopaminergic neurones and loss of substantia nigra input to corpus striatum
Can be treated with levodaopa which is coverted to dopamine by DOPA decarboxylase
Can be treated by carbidopa which inhibits AADC and cannot cross the BBB so it increases the level of L-DOPA in the periphery which can then cross the BBB and can be converted to dopamine in the brain
What is the association between Schizophrenia and dopamine pathways
Schizophrenia is assocaited with too much dopamine release
Treated using antipsychotics which antagonise dopamine D2 receptors